{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:16:51Z","timestamp":1787001411919,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":7726,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1023\/a:1008485722472","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:30:06Z","timestamp":1040549406000},"page":"1219-1227","source":"Crossref","is-referenced-by-count":47,"title":["Elderly patients with non-Hodgkin\u2019s lymphoma: Population-based results in the Netherlands"],"prefix":"10.1016","volume":"9","author":[{"given":"E.","family":"Maartense","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Kluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.A.","family":"Van Deijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Snijder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.W.","family":"Wijermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Noordijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008485722472_bb0010","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1200\/JCO.1988.6.11.1708","article-title":"Non-Hodgkin\u2019s lymphomas in 137 patients aged 70 years or older: A retrospective European Organisation for Research and Treatment of Cancer lymphoma group study","volume":"6","author":"Tirelli","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0015","first-page":"13","article-title":"Mitoxantrone in combination with etoposide and prednimustine in patients older than 70 years with unfavorable non-Hodgkin\u2019s lymphoma: A prospective study in 52 patients","volume":"31","author":"Tirelli","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008485722472_bb0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/oxfordjournals.annonc.a058727","article-title":"P-VEBEC: A new eight-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin\u2019s lymphoma (NHL)","volume":"5","author":"Bertini","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008485722472_bb0025","first-page":"379","article-title":"Non-Hodgkin\u2019s lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry","volume":"3","author":"d\u2019Amore","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008485722472_bb0030","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0959-8049(94)90158-9","article-title":"Aggressive non-Hodgkin\u2019s lymphoma in elderly patients: Where to go from here?","volume":"30A","author":"Obrist","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008485722472_bb0035","series-title":"Incidence of Cancer in The Netherlands 1989: First Report of the Netherlands Cancer Registry","first-page":"59","article-title":"Non-Hodgkin\u2019s lymphoma","author":"Otter","year":"1990"},{"key":"10.1023\/A:1008485722472_bb0040","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/1097-0142(19901101)66:9<1991::AID-CNCR2820660924>3.0.CO;2-4","article-title":"Non-Hodgkin\u2019s lymphoma in the elderly","volume":"66","author":"Carbone","year":"1990","journal-title":"Cancer"},{"key":"10.1023\/A:1008485722472_bb0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/oxfordjournals.annonc.a058722","article-title":"What treatment for elderly patients with aggressive lymphoma?","volume":"5","author":"Coiffier","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008485722472_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/1097-0142(197908)44:2<347::AID-CNCR2820440202>3.0.CO;2-9","article-title":"A critical analysis of the classification of non-Hodgkin\u2019s lymphomas","volume":"44","author":"Nathwani","year":"1979","journal-title":"Cancer"},{"key":"10.1023\/A:1008485722472_bb0055","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: Summary and description of a working formulation for clinical usage","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1023\/A:1008485722472_bb0060","series-title":"Histopathology of Non-Hodgkin\u2019s Lymphomas","author":"Lennert","year":"1992"},{"key":"10.1023\/A:1008485722472_bb0065","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A Revised European\u2013American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008485722472_bb0070","first-page":"1860","article-title":"Report of the committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008485722472_bb0075","first-page":"218","article-title":"Klinische Stadieneinteilung der Nicht-Hodgkin-Lymphome","volume":"153","author":"Musshoff","year":"1977","journal-title":"Strahlentherapie"},{"key":"10.1023\/A:1008485722472_bb0080","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0277-5379(89)90416-1","article-title":"on behalf of the Study Group. Primary extranodal and nodal non-Hodgkin\u2019s lymphoma, a survey of a population-based registry","volume":"25","author":"Otter","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0085","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.1996.14.7.2131","article-title":"Clinical significance of bcl-2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study","volume":"14","author":"Kramer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0090","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008485722472_bb0095","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.1988.6.12.1838","article-title":"The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin\u2019s lymphoma","volume":"6","author":"Vose","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0100","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/annonc\/5.suppl_2.S47","article-title":"Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin\u2019s lymphoma treated with standard-dose adriamycin-based regimens","volume":"5","author":"Grogan","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008485722472_bb0105","series-title":"Incidence of Cancer in The Netherlands 1989: First Report of The Netherlands Cancer Registry","first-page":"25","article-title":"Methods","author":"Otter","year":"1990"},{"key":"10.1023\/A:1008485722472_bb0110","series-title":"Cancer Incidence and Survival in the Southeast of The Netherlands 1955\u20131994: A report from the Eindhoven Cancer Registry","first-page":"107","article-title":"Comorbidity in newly diagnosed patients with cancer","author":"Coebergh","year":"1995"},{"key":"10.1023\/A:1008485722472_bb0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1532-5415.1984.tb02020.x","article-title":"Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: Increased complications with advancing age","volume":"32","author":"Armitage","year":"1984","journal-title":"J Am Geriatr Soc"},{"key":"10.1023\/A:1008485722472_bb0120","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0002-9343(87)90944-2","article-title":"Age as the main prognosticfactor in adult aggressive non-Hodgkin\u2019s lymphoma","volume":"83","author":"Solal-Celigny","year":"1987","journal-title":"Am J Med"},{"key":"10.1023\/A:1008485722472_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1986.4.3.295","article-title":"Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience","volume":"4","author":"Dixon","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0130","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1200\/JCO.1993.11.12.2362","article-title":"P-VABEC: A prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin\u2019s lymphoma","volume":"11","author":"Martelli","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0135","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1200\/JCO.1993.11.11.2250","article-title":"In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: Results of a phase II study of P\/DOCE chemotherapy","volume":"11","author":"O\u2019Reilly","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0140","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/86.17.1346","article-title":"Aggressive non-Hodgkin\u2019s lymphoma in the elderly: An effective, well-tolerated treatment regimen containing extended-schedule etoposide","volume":"86","author":"Young","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008485722472_bb0145","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1200\/JCO.1997.15.8.2945","article-title":"Elderly patients with aggressive non-Hodgkin\u2019s lymphoma: Disease presentation, response to treatment, and survival. A Groupe d\u2019Etude des Lymphomes de l\u2019Adulte study on 453 patients older than 69 years","volume":"15","author":"Bastion","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/bjc.1990.238","article-title":"Full-dose chemotherapy in elderly patients with non-Hodgkin\u2019s lymphoma: A feasibility study using a mitoxantrone containing regimen","volume":"62","author":"Sonneveld","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008485722472_bb0155","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/0959-8049(94)90183-X","article-title":"Non-Hodgkin\u2019s lymphoma in elderly patients: A phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology","volume":"30A","author":"Bessel","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008485722472_bb0160","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.1995.13.10.2530","article-title":"Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin\u2019s lymphoma using CHOP versus CNOP chemotherapy","volume":"13","author":"Sonneveld","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.1998.16.1.27","article-title":"CHOP is the standard regimen in patients of 70 years or more with intermediate and high grade non-Hodgkin\u2019s lymphoma: Results of a randomized study of EORTC lymphoma cooperative study group","volume":"16","author":"Tirelli","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"for the non-Hodgkin\u2019s Lymphoma Classification Project. Epidemiology of the non-Hodgkin\u2019s lymphomas: Distributions of the major subtypes differ by geographic locations","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008485722472_bb0175","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1182\/blood.V88.11.4085.bloodjournal88114085","article-title":"Lymphoma classification \u2013 the gap between biology and clinical management is closing","volume":"88","author":"Hiddemann","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008485722472_bb0180","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin\u2019s Lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008485722472_bb0185","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1023\/A:1008205619617","article-title":"Effect of age on the characteristics and clinical behavior of non-Hodgkin\u2019s lymphoma patients","volume":"8","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008485722472_bb0190","first-page":"370","article-title":"Factors affecting reduced survival of the elderly with intermediate- and high-grade lymphoma An analysis of SWOG 8516(INT 0067) \u2013 the National High Priority Lymphoma Study \u2013 a randomized comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B","volume":"3","author":"Gaynor","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008485722472_bb0195","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/oxfordjournals.annonc.a010801","article-title":"Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin\u2019s lymphoma treated with a pirarubicin-combination chemotherapy regimen","volume":"7","author":"Guerci","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008485722472_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1040-8428(97)10028-2","article-title":"Lymphomas","volume":"27","author":"Monfardini","year":"1998","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1023\/A:1008485722472_bb0205","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V86.4.1460.bloodjournal8641460","article-title":"International Prognostic Index for aggressive non-Hodgkin\u2019s lymphoma is valid for all malignancy grades","volume":"86","author":"Hermans","year":"1995","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419616224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419616224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/11\/1219\/19481448\/9-11-1219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T20:26:12Z","timestamp":1582230372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419616224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["S0923753419616224"],"URL":"https:\/\/doi.org\/10.1023\/a:1008485722472","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}